Organisation paid for research Program year 2025 Source: CMS Open Payments

Neurovations

Neither a doctor nor a teaching hospital

Research payments

$559,011

55 payments

Through program year 2025, Neurovations is reported as receiving $559,011 in research payments, across 55 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$22,377	2
2024	Research	$90,171	8
2023	Research	$29,556	11
2022	Research	$142,424	10
2021	Research	$160,343	14
2020	Research	$114,140	10

Breakdown

Who paid Research payments · program years 2020–2025

Medtronic, Inc. $454,987 45 payments
Neuronetics, Inc. $45,000 1 payment
Amgen Inc. $31,015 3 payments
Seikagaku Corporation $15,085 3 payments
Novartis Pharmaceuticals Corporation $12,924 3 payments

Studies the money was for Research payments · program years 2020–2025

Psr-Tdd $344,268 21 payments
Psr-Pstm $99,506 21 payments
Chronic Comorbid Pain Study Milestone 1 $45,000 1 payment
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of HZN-1116 in Participants With Sjgren's Syndrome $19,283 1 payment
6603/1133 $15,085 3 payments
A 5-Year, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Assessing the Efficacy, Safety, and Tolerability of Intra-Articular Regimens of Lna043 Versus Placebo in Patients With Symptomatic Knee Osteoarthritis $12,924 3 payments
Painful Diabetic Neuropathy $11,213 3 payments
P2 HZN-1116-201 Sjogren's Syndrome SS $8,639 1 payment
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity $3,094 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.